SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Emerging Infectious Diseases 2023, Vol.29 (6), p.1162
Hauptverfasser: Bloomfield, Lauren E, Ngeh, Sera, Cadby, Gemma, Hutcheon, Kate, Effler, Paul V
Format: Report
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 1162
container_title Emerging Infectious Diseases
container_volume 29
creator Bloomfield, Lauren E
Ngeh, Sera
Cadby, Gemma
Hutcheon, Kate
Effler, Paul V
description
doi_str_mv 10.3201/eid2906.230130
format Report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracgeneralonefile_A752184152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A752184152</galeid><sourcerecordid>A752184152</sourcerecordid><originalsourceid>FETCH-gale_infotracgeneralonefile_A7521841523</originalsourceid><addsrcrecordid>eNqVzUFLAzEQBeAcFFq1V8_zA5o6md2t7XEpFb1UsaXXMsRkGVknstn6-43iH_D04PE9njG3DhcVobsL8kZrXC6oQlfhhZk6XKFdYo0Tc5XzO6IrbD013b593dtNOlqCI3svGmAbY_CjfAUNOQN3LJpHeP4QPyQtahDWEUThSX9hUrvjwuElfZ57_inm0J7zOHAvPAdCohtzGbnPYfaX18Y-bA-bR9txH06iMRXtu3JZRklDlFK39w25Ve0aqv7rvwEonlFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Bloomfield, Lauren E ; Ngeh, Sera ; Cadby, Gemma ; Hutcheon, Kate ; Effler, Paul V</creator><creatorcontrib>Bloomfield, Lauren E ; Ngeh, Sera ; Cadby, Gemma ; Hutcheon, Kate ; Effler, Paul V</creatorcontrib><identifier>ISSN: 1080-6040</identifier><identifier>DOI: 10.3201/eid2906.230130</identifier><language>eng</language><publisher>U.S. National Center for Infectious Diseases</publisher><subject>Control ; Epidemics ; Statistics</subject><ispartof>Emerging Infectious Diseases, 2023, Vol.29 (6), p.1162</ispartof><rights>COPYRIGHT 2023 U.S. National Center for Infectious Diseases</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,860,4476,27902</link.rule.ids></links><search><creatorcontrib>Bloomfield, Lauren E</creatorcontrib><creatorcontrib>Ngeh, Sera</creatorcontrib><creatorcontrib>Cadby, Gemma</creatorcontrib><creatorcontrib>Hutcheon, Kate</creatorcontrib><creatorcontrib>Effler, Paul V</creatorcontrib><title>SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022</title><title>Emerging Infectious Diseases</title><subject>Control</subject><subject>Epidemics</subject><subject>Statistics</subject><issn>1080-6040</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2023</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqVzUFLAzEQBeAcFFq1V8_zA5o6md2t7XEpFb1UsaXXMsRkGVknstn6-43iH_D04PE9njG3DhcVobsL8kZrXC6oQlfhhZk6XKFdYo0Tc5XzO6IrbD013b593dtNOlqCI3svGmAbY_CjfAUNOQN3LJpHeP4QPyQtahDWEUThSX9hUrvjwuElfZ57_inm0J7zOHAvPAdCohtzGbnPYfaX18Y-bA-bR9txH06iMRXtu3JZRklDlFK39w25Ve0aqv7rvwEonlFY</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Bloomfield, Lauren E</creator><creator>Ngeh, Sera</creator><creator>Cadby, Gemma</creator><creator>Hutcheon, Kate</creator><creator>Effler, Paul V</creator><general>U.S. National Center for Infectious Diseases</general><scope/></search><sort><creationdate>20230601</creationdate><title>SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022</title><author>Bloomfield, Lauren E ; Ngeh, Sera ; Cadby, Gemma ; Hutcheon, Kate ; Effler, Paul V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracgeneralonefile_A7521841523</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Control</topic><topic>Epidemics</topic><topic>Statistics</topic><toplevel>online_resources</toplevel><creatorcontrib>Bloomfield, Lauren E</creatorcontrib><creatorcontrib>Ngeh, Sera</creatorcontrib><creatorcontrib>Cadby, Gemma</creatorcontrib><creatorcontrib>Hutcheon, Kate</creatorcontrib><creatorcontrib>Effler, Paul V</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bloomfield, Lauren E</au><au>Ngeh, Sera</au><au>Cadby, Gemma</au><au>Hutcheon, Kate</au><au>Effler, Paul V</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022</atitle><jtitle>Emerging Infectious Diseases</jtitle><date>2023-06-01</date><risdate>2023</risdate><volume>29</volume><issue>6</issue><spage>1162</spage><pages>1162-</pages><issn>1080-6040</issn><pub>U.S. National Center for Infectious Diseases</pub><doi>10.3201/eid2906.230130</doi></addata></record>
fulltext fulltext
identifier ISSN: 1080-6040
ispartof Emerging Infectious Diseases, 2023, Vol.29 (6), p.1162
issn 1080-6040
language eng
recordid cdi_gale_infotracgeneralonefile_A752184152
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access
subjects Control
Epidemics
Statistics
title SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A01%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=SARS-CoV-2%20Vaccine%20Effectiveness%20against%20Omicron%20Variant%20in%20Infection-Naive%20Population,%20Australia,%202022&rft.jtitle=Emerging%20Infectious%20Diseases&rft.au=Bloomfield,%20Lauren%20E&rft.date=2023-06-01&rft.volume=29&rft.issue=6&rft.spage=1162&rft.pages=1162-&rft.issn=1080-6040&rft_id=info:doi/10.3201/eid2906.230130&rft_dat=%3Cgale%3EA752184152%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A752184152&rfr_iscdi=true